EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute Alcohol‐Induced Changes Measured With Metabotropic Glutamate Receptor 5 Positron Emission Tomography

Nakul R Raval iD, Kelly Smart, Gustavo A Angarita iD, Rachel Miller, Yiyun Huang, John H Krystal, Richard E Carson, Kelly P Cosgrove, Stephanie S O'Malley, Ansel T Hillmer

Addiction Biology · 2025

DOI: 10.1111/adb.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, 2025. Verfasst von Nakul R Raval und 9 weiteren Autor:innen. Beteiligte Einrichtung: Yale PET Center, Yale University, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Receptor, Metabotropic Glutamate 5, Ethanol, Brain. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, State of Connecticut, Department of Mental Health, and Addiction Services for the Clinical Neuroscience Research Unit, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alcohol consumption at clinically relevant doses alters brain glutamate release. However, few techniques exist to measure these changes in humans. The metabotropic glutamate receptor 5 (mGluR5) PET radioligand [ 11 C]ABP688 is sensitive to acute alcohol in rodents, possibly mediated by alcohol effects on glutamate release. This study aimed to determine the sensitivity of [ 11 C]ABP688 PET to an acute alcohol challenge in humans.

Methods

Eight social drinkers (25–42 years; 5 females) with a recent drinking occasion achieving a blood alcohol level (BAL) > 80 mg/dL were recruited. All participants underwent a 90‐min dynamic baseline [ 11 C]ABP688 PET scan. Two weeks later (range: 7–29 days), participants completed an oral laboratory alcohol challenge over 30 min, targeting a BAL of 60 mg/dL. Immediately after the challenge, a second [ 11 C]ABP688 PET scan was performed. Non‐displaceable binding potential ( BP ND ; indicative of mGluR5 availability) and R 1 (indicative of relative blood flow) were estimated using the simplified reference tissue model with the cerebellum as the reference region. Blood samples were taken throughout the scanning procedure to measure the BAL.

Results

Seven participants (4 females) completed the study. The mean peak BAL achieved was 61 ± 18 mg/dL. Acute alcohol significantly decreased [ 11 C]ABP688 BP ND , F (1, 42) = 17.05, p < 0.001, Cohen's d = 0.32–0.60, and increased [ 11 C]ABP688 R 1 , F (1, 42) = 6.67, p = 0.013, Cohen's d = 0.32–0.48, across brain regions. Exploratory analysis showed a positive relationship between alcohol‐induced % change in [ 11 C]ABP688 R 1 in cortical regions and peak BAL (Spearman rho = 0.78 [frontal cortex] and 0.85 [temporal cortex] = 0.024 and 0.011).

Conclusions

This proof‐of‐concept study demonstrates that [ 11 C]ABP688 PET imaging is sensitive to the effects of acute alcohol consumption. The observed decrease in mGluR5 availability aligns with preclinical data potentially indicating acute increased extracellular glutamate concentrations following ethanol dosing. This imaging tool could be useful for future investigations into the acute effects of alcohol on the brain during abstinence and withdrawal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyReceptor, Metabotropic Glutamate 5EthanolBrainAlcohol DrinkingCentral Nervous System DepressantsHumansFemaleAdultMaleOximesPyridinesCarbon RadioisotopesRadiopharmaceuticals

Stichwörter der Autor:innen

alcohol challengeglutamate releasemetabotropic glutamate type 5 receptorspositron emission tomographysocial drinkers

Substanzen

Receptor, Metabotropic Glutamate 5OximesEthanolPyridines3-(6-methylpyridin-2-ylethynyl)cyclohex-2-enone-O-methyloximeCarbon RadioisotopesCentral Nervous System DepressantsRadiopharmaceuticalsGRM5 protein, human

Autor:innen und Institutionen

  • Yale PET Center, Yale University, New Haven, Connecticut, USA.
  • Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut, USA.
  • Department of Psychiatry, Yale University, New Haven, Connecticut, USA.
  • Connecticut Mental Health Center, New Haven, Connecticut, USA.

ORCID-Profile: Nakul R Raval, Gustavo A Angarita

Förderung

  • NIAAA NIH HHS
  • State of Connecticut, Department of Mental Health, and Addiction Services for the Clinical Neuroscience Research Unit
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Raval, N. R., Smart, K., Angarita, G. A., Miller, R., Huang, Y., Krystal, J. H., Carson, R. E., Cosgrove, K. P., O'Malley, S. S., & Hillmer, A. T. (2025). Acute Alcohol‐Induced Changes Measured With Metabotropic Glutamate Receptor 5 Positron Emission Tomography. Addiction Biology. https://doi.org/10.1111/adb.70031

Vancouver

Raval NR, Smart K, Angarita GA, Miller R, Huang Y, Krystal JH, et al. Acute Alcohol‐Induced Changes Measured With Metabotropic Glutamate Receptor 5 Positron Emission Tomography. Addiction Biology. 2025. doi:10.1111/adb.70031

BibTeX
@article{Raval2025,
  author = {Raval, Nakul R and Smart, Kelly and Angarita, Gustavo A and Miller, Rachel and Huang, Yiyun and Krystal, John H and Carson, Richard E and Cosgrove, Kelly P and O'Malley, Stephanie S and Hillmer, Ansel T},
  title = {Acute Alcohol‐Induced Changes Measured With Metabotropic Glutamate Receptor 5 Positron Emission Tomography},
  journal = {Addiction Biology},
  year = {2025},
  doi = {10.1111/adb.70031}
}
Kostenlos starten →